A PBN-RL-XAI Framework for Discovering a "Hit-and-Run" Therapeutic Strategy in Melanoma

Zhonglin Liu

Innate resistance to anti-PD-1 immunotherapy remains a major clinical challenge in metastatic melanoma, with the underlying molecular networks being poorly understood. To address t…